Cidara Therapeutics (CDTX) SEC Filings & 10K Form

$13.05
-0.39 (-2.90%)
(As of 05/8/2024 ET)

Recent Cidara Therapeutics SEC Filings

DateFilerForm TypeView
05/03/2024
7:00 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
3:34 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
3:37 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:07 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:09 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
4:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
7:02 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
7:00 AM
Cidara Therapeutics (Filer)
Form NT 10-K
03/20/2024
5:46 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:47 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:47 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:48 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:48 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:45 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:46 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:47 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:48 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:48 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:22 PM
Cidara Therapeutics (Filer)
Form DEF 14A
02/14/2024
9:18 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cidara Therapeutics (Subject)
Form SC 13G/A
02/09/2024
7:00 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
6:33 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
12:22 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
9:36 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
12:24 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
3:22 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:24 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
7:05 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
6:40 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
5:04 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:31 PM
Canale-Theakston Carin (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:33 PM
Cidara Therapeutics (Issuer)
Mineo Chrysa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:19 PM
BURGESS DANIEL D (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:21 PM
Cidara Therapeutics (Issuer)
Franson Timothy R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:23 PM
Cidara Therapeutics (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:15 PM
Cidara Therapeutics (Issuer)
Gollaher David L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:17 PM
Bassler Bonnie L (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:07 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CDTX) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners